September 27, 2007 - Siemens has extended the expiration date for the cash tender offer for all outstanding shares of Dade Behring Holdings Inc. to Wednesday, Oct. 31, as Siemens awaits merger control clearance by the European Commission for a transaction that has a value of approximately $7 billion.

Penn Presbyterian Medical Center, a University of Pennsylvania Health System hospital, is rated one of the top 100 Top Hospitals for cardiovascular care by Solucient — a distinction it has received for five consecutive years. Located in Philadelphia, the 350-bed facility has a long history of providing products and procedures that improve patient care.

September 26, 2007 - Rcadia Medical Imaging Ltd., developer of novel computer-aided diagnostic software, has received a second FDA clearance to market its COR Analyzer family of products, which assists in triaging patients for coronary artery disease (CAD).

September 26, 2007 - Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, announces today that it has completed the installation of its IMPAX Cardiovascular Suite at the AZ Imelda hospital in Bonheiden, Belgium, providing an integrated view of patient data from a single point of access.

September 25, 2007 – ScottCare Corp., a noninvasive external counterpulsation (ECP) therapy and cardiopulmonary rehabilitation telemetry maker, said it completed the acquisition of Rozinn Electronics Inc., a privately-held manufacturer of cardiovascular diagnostic equipment based in Glendale, NY.

September 25, 2007 - Abbott Laboratories said it is working with the FDA Administration to schedule an advisory panel review Nov. 29, 2007, for the company’s Xience drug-coated stent heart device.

Any panel recommendations and follow-up decision from the FDA would also cover the Promus coated stent made by Boston Scientific Corp. because Promus and Xience are the same device, but are sold under different labels. Boston Scientific shares Promus profit with Abbott through an agreement reached last year when the two companies bought parts of Guidant Corp.

September 25, 2007 - Cordis Corp. today announced the introduction in the U.S. market of the FIRE STAR Rx PTCA Dilatation Catheter and the DURA STAR Rx PTCA Dilatation Catheter starting on Oct. 15, 2007, as the company builds its portfolio of products and services to support interventional cardiologists and cath lab teams.

September 25, 2007 - Abbott enrolled the first patient in HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to Demonstrate Efficacy and Safety), a U.S. clinical trial designed to evaluate the safety and effectiveness of the investigational RX Herculink Elite Renal Stent System to treat patients with renal artery stenosis (RAS).

September 25, 2007 - The risk of developing venous thromboembolism while flying on an airplane, a condition known as “economy class syndrome,” is only about one in 5,000 for long flights, although the odds of in-flight clot are higher for some groups, according to a new study out of The Netherlands.

September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application (sNDA) for a modified dosing regimen of Angiomax (bivalirudin) for the treatment of acute coronary syndromes (ACS), specifically in patients with unstable angina or non-segment elevation myocardial infarction (NSTEMI), which could replace heparin in patients undergoing angioplasty.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now